Eva M. Verdugo‐Sivianes

Downregulation of MYPT1 increases tumor resistance in ovarian cancer by targeting the Hippo pathway and increasing the stemness

Sandra Muñoz-Galván, Blanca Felipe‐Abrio, Eva M. Verdugo‐Sivianes et al. · Molecular Cancer · 2020 · 121 citations · Full text

Medicine, Cancer Biology, Oncology +17

The Cargo Protein MAP17 (PDZK1IP1) Regulates the Cancer Stem Cell Pool Activating the Notch Pathway by Abducting NUMB

José Manuel García-Heredia, Antonio Lucena-Cacace, Eva M. Verdugo‐Sivianes et al. · Clinical Cancer Research · 2017 · 81 citations · Full text

Medicine, Cell Biology, Oncology +17

Numb-like (NumbL) downregulation increases tumorigenicity, cancer stem cell-like properties and resistance to chemotherapy

José Manuel García-Heredia, Eva M. Verdugo‐Sivianes, Antonio Lucena-Cacace et al. · Oncotarget · 2016 · 47 citations · Full text

Medicine, Molecular Biology, Oncology +17

New markers for human ovarian cancer that link platinum resistance to the cancer stem cell phenotype and define new therapeutic combinations and diagnostic tools

Sandra Muñoz-Galván, Blanca Felipe‐Abrio, Miguel García-Carrasco et al. · Journal of Experimental & Clinical Cancer Research · 2019 · 41 citations · Full text

Medicine, Bioinformatics, Oncology +17

Loss of the tumor suppressor spinophilin (PPP1R9B) increases the cancer stem cell population in breast tumors

Irene Ferrer, Eva M. Verdugo‐Sivianes, María Ángeles Castilla et al. · Oncogene · 2015 · 34 citations · Full text

Life Sciences, Molecular Biology, Oncology +16